Follow-Up: FDA Classifies 365 Whole Foods Ashwagandha Capsule Recall as Class I: 10,176 Bottles, Lot 202526227, Over Possible Salmonella

The U.S. Food and Drug Administration (FDA) on November 12, 2026 classified a recall by Vitality Works, Inc. of ashwagandha capsules as Class I, the agency's most serious recall category, meaning there is a reasonable probability that use of the product will cause serious adverse health consequences. The product is 365 Whole Foods Market Standardized + Full Spectrum Blend Ashwagandha Capsules, 120 count, totalling 10,176 bottles.
The recall covers a single lot: lot 202526227, expiring October 13, 2028, with UPC 099482520991 and product item number 3006661. The capsules are packaged in 200cc white plastic bottles, with a suggested use of one capsule twice daily. Consumers can identify the recalled product by the lot number and expiration date printed on the bottom of the bottle.
The lot was sold nationwide at Whole Foods Market stores and online at Amazon.com between November 24, 2025 and October 20, 2026. Vitality Works, based in Albuquerque, New Mexico, announced the recall on October 30, 2026, saying the potential contamination was discovered during routine sampling of a single retail unit.
The company and the FDA said no illnesses had been reported in connection with the product as of the announcement. The FDA's recall notice states that Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Consumers who have the recalled lot should not take the product.
Published by GSM · USA (original Chinese edition)
Photo: Wikimedia Commons, Cliff from I now live in Arlington, VA (Outside Washington DC), USA, CC BY 2.0

